Screening active anti-breast cancer compounds from Cortex Magnolia officinalis by 2D LC-MS

Journal of Separation Science

Volumn 36, Issue 4, 2013, Pages 706-712

  Hou, Xiaofang ^a   Yuan, Xilong ^a   Zhang, Bing ^a   Wang, Sicen ^a   Chen, Qinhua ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Active screening; Breast cancer cell; Cell membrane chromatography; Cortex Magnolia officinalis; Coupled analytical techniques

Indexed keywords

ACTIVE COMPOUNDS; BREAST CANCER; BREAST CANCER CELLS; CANCER DRUG; CELL MEMBRANE CHROMATOGRAPHIES; CHROMATOGRAPHIC STATIONARY PHASE; CORTEX MAGNOLIA OFFICINALIS; COUPLED ANALYTICAL TECHNIQUES; DRUG DISCOVERY; DRUG RESISTANCE; DRUG SCREENING; HPLC/MS; IN-VITRO; INHIBITION RATE; MAGNOLOL; MDA-MB-231 CELLS; RETENTION CHARACTERISTICS; TARGET COMPONENT; TRADITIONAL CHINESE MEDICINE;

CELL MEMBRANES; CYTOLOGY; DISEASES; DRUG PRODUCTS;

COLUMN CHROMATOGRAPHY;

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; HONOKIOL; MAGNOLIA OFFICINALIS EXTRACT; MAGNOLOL; PLANT EXTRACT;

ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL GROWTH; CELL MEMBRANE; CHINESE MEDICINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; IN VITRO STUDY; MAGNOLIA OFFICINALIS; MAGNOLIACEAE; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIPHENYL COMPOUNDS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, LIQUID; DRUG SCREENING ASSAYS, ANTITUMOR; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; LIGNANS; MAGNOLIA; MASS SPECTROMETRY;

EID: 84873637453     PISSN: 16159306     EISSN: 16159314     Source Type: Journal    
DOI: 10.1002/jssc.201200896     Document Type: Article

References (36)

1. Siegel, R., Naishadham, D., Jemal, A., CA Cancer J. Clin. 2012, 62, 10-29.
2. Hatake, K., Tokudome, N., Ito, Y., Intern. Med. 2007, 46, 149-150.
3. Rana, P., Sridhar, S. S., Breast Cancer 2012, 6, 67-77.
4. Zhao, H. Y., Huang, H., Hu, Z. H., Huang, Y., Lin, S. X., Tian, Y., Lin, T. Y., Anticancer Drugs 2012, 23, 534-542.
5. Kolacinska, A., Chalubinska, J., Zawlik, I., Szymanska, B., Borowska-Garganisz, E., Nowik, M., Fendler, W., Kubiak, R., Pawlowska, Z., Morawiec, Z., Szemraj, J., Neoplasma 2012, 59, 424-432.
6. Wong, S. T., Goodin, S., Pharmacotherapy 2009, 29, 954-965.
7. Newman, D. J., Cragg, G. M., Snader, K. M., J. Nat. Prod. 2003, 66, 1022-1037.
8. Koehn, F. E., Carter, G. T., Nat. Rev. Drug Discovery 2005, 4, 206-220.
9. Clardy, J., Walsh, C., Nature 2004, 432, 829-837.
10. Drews, J., Science 2000, 287, 1960-1964.
11. Schreiber, S. L., Science 2000, 287, 1964-1969.
12. He, L. C., Geng, X. D., New Prog. Biomed. Chromatogr. 1996, 3, 8-9.
13. He, L. C., Yang, G. D., Geng, X. D., Chinese Sci. Bull. 1999, 44, 826-831.
14. He, L. C., Wang, S. C., Geng, X. D., Chromatographia 2001, 54, 71-76.
15. Liang, M. J., He, L. C., Yang, G. D., Life Sci. 2005, 78, 128-133.
16. Wang, C. H., He, L. C., Wang, N., Liu, F., J. Chromatogr. B 2009, 877, 3019-3024.
17. Wang, Y., Yuan, B. X., Deng, X. L., He, L. C., Wang, S. C., Zhang, Y., Han, Q. D., Anal. Bioanal. Chem. 2006, 386, 2003-2011.
18. Du, H., Ren, J., Wang, S. C., He, L. C., Anal. Bioanal. Chem. 2011, 400, 3625-3633.
19. Wang, Y., Yuan, B. X., Deng, X. L., He, L. C., Zhang, Y. Y., Han, Q. D., Anal. Biochem. 2005, 339, 198-205.
20. Li, M., Wang, S. C., Zhang, Y. M., He, L. C., J. Pharm. Biomed. Anal. 2010, 53, 1063-1069.
21. Wang, S. C., Sun, M., Zhang, Y., Du, H., He, L. C., J. Chromatogr. A 2010, 1217, 5246-5252.
22. Luo, L., Nong Wang, J., Kong, L. D., Jiang, Q. G., Tan, R. X., J. Ethnopharmacol. 2000, 73, 277-281.
23. Riedlinger, J. E., Tan, P. W., Lu, W., Ann. Pharmacother. 2001, 35, 228-235.
24. Oh, J. H., Kang, L. L., Ban, J. O., Kim, Y. H., Kim, K. H., Han, S. B., Hong, J. T., Chem. Biol. Interact. 2009, 180, 506-514.
25. Fong, W. F., Tse, A. K., Poon, K. H., Wang, C., Int. J. Biochem. Cell Biol. 2005, 37, 427-441.
26. Choi, D. Y., Lee, Y. J., Hong, J. T., Lee, H. J., Brain Res. Bull. 2012, 87, 144-153.
27. Xu, Q., Yi, L. T., Pan, Y., Wang, X., Li, Y. C., Li, J. M., Wang, C. P., Kong, L. D., Prog. Neuropsychopharmacol. Biol. Psychiatr. 2008, 32, 715-725.
28. Lin, Y. R., Chen, H. H., Ko, C. H., Chan, M. H., Neuropharmacology 2005, 49, 542-550.
29. Li, Z., Liu, Y., Zhao, X., Pan, X., Yin, R., Huang, C., Chen, L., Wei, Y., Eur. J. Obstet. Gynecol. Reprod. Biol. 2008, 140, 95-102.
30. Lee, S. J., Cho, Y. H., Park, K., Kim, E. J., Jung, K. H., Park, S. S., Kim, W. J., Moon, S. K., Biochem. Pharmacol. 2008, 75, 2289-2300.
31. Beatson, B. T., Lancet 1896, 2, 104-107.
32. Lewis, J. S., Jordan, V. C., Mutat. Res. 2005, 591, 247-263.
33. Lin, S. L., Yan, L. Y., Zhang, X. T., Yuan, J., Li, M., Qiao, J., Wang, Z. Y., Sun, Q. Y., PloS One 2010, 5, e9013.
34. Wang, Z., Zhang, X., Shen, P., Loggie, B. W., Chang, Y., Deuel, T. F., Proc. Natl. Acad. Sci. USA 2006, 103, 9063-9068.
35. Zhang, X. T., Kang, L., Ding, L., Vranic, S., Gatalica, Z., Wang, Z. Y., Oncogene 2010, 30, 770-780.
36. Carter, C. A., Chen, C., Brink, C., Vincent, P., Maxuitenko, Y. Y., Gilbert, K. S., Waud, W. R., Zhang, X., Cancer Chemother. Pharmacol. 2007, 59, 183-195.